About: Lexatumumab

Lexatumumab (also known as ETR2-ST01) is an agonistic human monoclonal antibody against TRAIL-R2 (DR5, APO-2) used in the treatment of cancer. This drug was developed by Human Genome Sciences, Inc.

Property	Value
dbpedia-owl:Drug/atcPrefix	none
dbpedia-owl:Drug/casNumber	845816-02-6
dbpedia-owl:atcPrefix	none
dbpedia-owl:casNumber	845816-02-6
dbpprop:abstract	Lexatumumab (also known as ETR2-ST01) is an agonistic human monoclonal antibody against TRAIL-R2 (DR5, APO-2) used in the treatment of cancer. This drug was developed by Human Genome Sciences, Inc.
dbpprop:atcPrefix	none
dbpprop:c	6346 (xsd:integer)
dbpprop:casNumber	845816-02-6
dbpprop:h	9832 (xsd:integer)
dbpprop:hasPhotoCollection	http://www4.wiwiss.fu-berlin.de/flickrwrappr/photos/Lexatumumab
dbpprop:molecularWeight	143.6 kDa
dbpprop:n	1720 (xsd:integer)
dbpprop:o	2002 (xsd:integer)
dbpprop:reference	http://www.ama-assn.org/ama1/pub/upload/mm/365/lexatumumab.pdf
dbpprop:s	42 (xsd:integer)
dbpprop:source	Human
dbpprop:target	TRAIL-R2
dbpprop:type	mab
dbpprop:wikiPageUsesTemplate	dbpedia:Template:drugbox
rdf:type	owl:Thing dbpedia-owl:Drug http://dbpedia.org/class/yago/CancerTreatments http://dbpedia.org/class/yago/MonoclonalAntibodies
rdfs:comment	Lexatumumab (also known as ETR2-ST01) is an agonistic human monoclonal antibody against TRAIL-R2 (DR5, APO-2) used in the treatment of cancer. This drug was developed by Human Genome Sciences, Inc.
rdfs:label	Lexatumumab
owl:sameAs	http://umbel.org/umbel/ne/wikipedia/Lexatumumab freebase:Lexatumumab
skos:subject	dbpedia:Category:Monoclonal_antibodies dbpedia:Category:Cancer_treatments
foaf:page	http://en.wikipedia.org/wiki/Lexatumumab
is dbpprop:redirect of	dbpedia:Lexitumumab
is owl:sameAs of	yago:Lexatumumab